Objective
Chronic lateral epicondylosis (CLE) is common, debilitating and often refractory. Prolotherapy (PrT) is an injection therapy for tendinopathy. The efficacy of two PrT solutions for CLE was evaluated.
Design
3-arm randomized controlled trial. 26 adults (32 elbows) with ≥3 months of CLE were randomized to ultrasound-guided PrT with dextrose (PrT-D), PrT with dextrose-morrhuate (PrT-DM) or watchful waiting (Wait-and-see). The primary outcome was the Patient-Rated Tennis Elbow Evaluation (PRTEE; 100-points) at 4, 8 and 16 weeks, (all groups) and 32 weeks (PrT groups). Secondary outcomes included pain-free grip strength and magnetic resonance imaging (MRI) score.
Results
PrT-D and PrT-DM participants reported improved PRTEE composite and subscale scores at 4, 8 and/or 16 weeks compared to Wait-and-see (p<0.05). At 16 weeks, compared to baseline, PrT-D and PrT-DM groups improved composite PRTEE scores by 18.7±9.6 (41.1%) and 17.5±11.6 (53.5%) points, respectively. Grip strength of PrT-D participants exceeded that of PrT-DM and Wait-and-see at 8 and 16 weeks (p<0.05). There were no differences in MRI scores. Satisfaction was high; there were no adverse events.
Conclusions
Prolotherapy resulted in safe, significant improvement of elbow pain and function compared to baseline status and wait-and-see control. This pilot study suggests the need for a definitive trial.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.